Volume 12, Issue 1 (3-2024)                   JoMMID 2024, 12(1): 67-75 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shamanna P, Sethumadhavan M. Pneumocystis jirovecii in Respiratory Tract of Immunocompromised Patients: A Study in a Tertiary Care Center in Bangalore, South India. JoMMID 2024; 12 (1) :67-75
URL: http://jommid.pasteur.ac.ir/article-1-535-en.html
Department of Microbiology, Sanjay Gandhi Institute of Trauma and Orthopedics, Bangalore, India
Abstract:   (276 Views)
Introduction: Pneumocystis jirovecii pneumonia (PCP) remains a significant cause of pneumonia among immunocompromised individuals, despite a decline in prevalence with the advent of antiretroviral therapy (ART) for Human Immunodeficiency Virus (HIV). This study aimed to evaluate and compare the diagnostic accuracy of four distinct staining techniques for PCP in respiratory specimens. We assessed the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of these techniques against the gold standard Gomori Methenamine Silver stain (GMS), in order to identify the most effective method for diagnosing PCP. Methods: In a prospective observational study, we collected induced sputum (IS) and BAL samples from 100 immunocompromised patients and examined them microscopically for P. jirovecii cysts. We employed four staining methods for detection: Calcofluor White, Modified Toluidine Blue, Wright's stain, and Gomori Methenamine Silver stain. Results: The combination of Modified Toluidine Blue, Calcofluor White, and Wright's stains detected P. jirovecii cysts in 5% of the study population. The sensitivity of the staining methods was: 80% for Modified Toluidine Blue, 40% for Calcofluor White, and 20% for Wright's, compared to the Gomori Methenamine Silver (GMS) stain, which was used as the gold standard. All the staining methods exhibited equivalent specificity (100%). Conclusion: The Modified Toluidine Blue stain is a viable alternative to the Gomori Methenamine Silver stain due to its simplicity, speed, and applicability in resource-limited settings. The low prevalence of P. jirovecii in this study population suggests that routine cotrimoxazole prophylaxis may be effective in reducing the incidence of P. jirovecii pneumonia among HIV patients.  
Full-Text [PDF 847 kb]   (103 Downloads)    
Type of Study: Original article | Subject: Diagnostic/screening methods and protocols
Received: 2023/04/20 | Accepted: 2024/05/21 | Published: 2024/06/8

1. Singhal R, Mirdha BR, Guleria R. Human Pneumocystosis. Indian J Chest Allied Sci. 2005; 47 (4): 273-83.
2. Truong, J, Ashurst JV. (2023). Pneumocystis jirovecii pneumonia. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482370.
3. Smith JW, Hughes WT. A rapid staining technique for Pneumocystis carinii. J Clin Pathol. 1972; 25 (3): 269-71. [DOI:10.1136/jcp.25.3.269] [PMID] []
4. Mathews SM, Mathai E. Emerging Importance of Pneumocystis carinii among Indian Immunosuppressed Patients. Indian J Chest Dis Allied Sci. 2000; 42 (4): 323-4.
5. Ibrahim A, Chattaraj A, Iqbal Q, Anjum A, Rehman MEU, Aijaz, Z, et al. Pneumocystis jirovecii Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients. Avicenna J Med. 2023; 13 (1): 23-34. [DOI:10.1055/s-0043-1764375] [PMID] []
6. Mirdha BR, Guleria R.Comparitive yield of different respiratory samples for diagnosis of Pneumocystis carinii infections in HIV seronegative and seropositive individuals in India. Southeast Asian J Trop Med Public Health. 2000; 31 (3): 473-7.
7. Veintimilla C, Álvarez-Uría A, Martín-Rabadán P, Valerio M, Machado M, Padilla B. Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre. J Fungi. 2023; 9 (4): 414. [DOI:10.3390/jof9040414] [PMID] []
8. Cregan P, Yamamoto A, Lum A, Van Der Heide T, MacDonald M, Pulliam L. Comparison of Four Methods for Rapid Detection of Pneumocystis carinii in Respiratory Specimens. J Clin Microbiol. 1990; 28 (11): 2432-6. [DOI:10.1128/jcm.28.11.2432-2436.1990] [PMID] []
9. Mirdha BR, Guleria R.Comparitive yield of different respiratory samples for diagnosis of Pneumocystis carinii infections in HIV seronegative and seropositive individuals in India. Southeast Asian J Trop Med Public Health. 2000; 31 (3): 473-7.
10. Usha Rani N, Reddy VVR, Prem Kumar A, Vijay Kumar KVV, Ravindra Babu G, Babu Rao D. Clinical Profile of Pneumocystis carinii Pneumonia in HIV Infected Persons. Ind J Tub. 2000; 47: 93-6.
11. Russian DA, Kovacs JA. Pneumocystis carinii in Africa: An emerging pathogen. Lancet. 1995; 346 (8985): 1242-3. [DOI:10.1016/S0140-6736(95)91854-X] [PMID]
12. Standard Operative Procedures for Mycology, St. John"s Laboratory Services: Section Microbiology. 2006: 33-38.
13. Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB et al. Detection of Pneumocystis jirovecii in Respiratory Specimens by Four Staining Methods. J Clin Microbiology. 2004; 42 (7): 3333-5. [DOI:10.1128/JCM.42.7.3333-3335.2004] [PMID] []
14. Gosey LL, Howard RM, Witebsky FG, Ognibene FP, Wu TC, Gill VJ, et al. Advantages of a Modified Toluidine Blue O stain and Bronchoalveolar Lavage for the Diagnosis of Pneumocystis carinii Pneumonia. J Clin Microbiol. 1985; 22 (5): 803-7. [DOI:10.1128/jcm.22.5.803-807.1985] [PMID] []
15. Garcia LS. Diagnostic Medical Parasitology 4th ed. ASM Press. Washington; 2001.Chapter 30. Sputum, Aspirates and Biopsy Material; 809-28. Chapter 31. Procedures for detecting Blood Parasites; 829-49.
16. Kim HK, Hughes WT. Comparison of Methods for Identification of Pneumocystis carinii in Pulmonary Aspirates. Am J Clin Pathol. 1972; 60 (4): 462-6. [DOI:10.1093/ajcp/60.4.462] [PMID]
17. Udwadia ZF, Doshi AV, Bhaduri AS. Pneumocystis carinii pneumonia in HIV infected patients from Mumbai. JAPI. 2005; 53: 437-40.
18. Usha MM, Rajendran P, Thyagarajan SP, Solomon S, Kumarasamy N, Yepthomi T, et al. Identification of Pneumocystis carinii in induced sputum of AIDS patients in Chennai (Madras). Indian J Pathol Microbiol. 2000; 43 (3): 291-6.
19. Kaur R, Panda PS, Dewan R. Profile of pneumocystis infection in a tertiary care institute in North India. Indian J Sex Transm Dis AIDS. 2016; 37 (2): 143-6. [DOI:10.4103/0253-7184.185501] [PMID] []
20. Bigby TD, Margolskee D, Curtis JL, Michael PF, Sheppard D, Hadley WK, et al. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis. 1986; 133 (4): 515-8.
21. Taqi SA, Zaki SA, Nilofer AR, Sami LB. Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient. 2012; 44 (4): 533-5. [DOI:10.4103/0253-7613.99346] [PMID] []
22. Dworkin MS, Williamson F, Jones JL, Kaplan JE. Prophylaxis with trimethoprim-sulphamethoxazole for HIV infected patients: impact on risk for infectious disease. Clin Infect Dis. 2001; 33 (3): 393-8. [DOI:10.1086/321901] [PMID]
23. Kumaraswamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003; 36 (1): 79-85. [DOI:10.1086/344756] [PMID]
24. Varnas D, Jankauskienė A. Pneumocystis Jirovecii Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review. Acta Med Litu. 2021; 28 (1): 136-44. [DOI:10.15388/Amed.2020.28.1.5] [PMID] []
25. Branten AJ, Beckers PJ, Tiggeler GW, Hiotsma AJ. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant. 1995; 10 (7): 1194-7. [DOI:10.1093/ndt/10.7.1194] [PMID]
26. Baselski VS, Robison MK, Pifer LW, Woods DR. Rapid Detection of Pneumocystis carinii in Bronchoalveolar Lavage Samples by Using Calcofluor Staining. J Clin Microbiol. 1990; 28 (2): 393-4. [DOI:10.1128/jcm.28.2.393-394.1990] [PMID] []
27. NG VL, Yajko DM, McPhaul LW, Gartner I, Byford B, Goodman CD, et al. Evaluation of an indirect fluorescent antibody stain for detection of Pneumocystis carinii in Respiratory specimens. J Clin Microbiol. 1990; 28 (5): 975-9. [DOI:10.1128/jcm.28.5.975-979.1990] [PMID] []
28. Sridharan G, Shankar AA. Toluidine blue: A review of its chemistry and clinical utility. J Oral Maxillofac Pathol. 2012; 16 (2): 251-5. [DOI:10.4103/0973-029X.99081] [PMID] []

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.